ACCELLENA
Research & Development
2026
Research & Development
2026
Facilitating R&D processes in early-stage scientific development in biology and medicine
Amidst growing bureaucratic burdens, we provided researchers with professional support in matters concerning the interaction of their work with government agencies and society.
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.
About the project
The project took on most of the administrative tasks and associated risks that arise when implementing discoveries, while ensuring the protection of interests of both the developers themselves and the organizations they worked for.
The following projects were implemented within the framework of Early Birds:
The following projects were implemented within the framework of Early Birds:
- TAARGain
- Repertoire
- StereotaX
StereotaX
A science club that brings together specialists, researchers, students, and professionals from the pharmaceutical, biotech, clinical research, and IT industries around the most pressing topics in medicine, pharma, biology, and technology. The project was launched in 2023 as part of the Early Birds initiative.
The name StereotaX is derived from the term "stereotactic surgery" and reflects the project’s core idea: to get straight to the heart of complex scientific questions. This is also where the club’s motto comes from: #straighttothebrain.
With its informal format, StereotaX goes beyond conventional presentations and formal debates. Members discuss real-world industry challenges, exchange perspectives, and collaboratively seek solutions that could lay the groundwork for future projects and research.
StereotaX focuses on topics that span the entire journey of modern medical science — from fundamental research to the implementation of solutions in clinical practice.
Key areas of interest include:
— Clinical trials and development of research infrastructure;
— Drug discovery and development;
— Preclinical research, GLP standards, and scientific data quality;
— Oncology and novel therapeutic approaches;
— Microbiology, infectious diseases, biomedicine, and biotechnology;
— Chemistry as a foundation for new pharmaceutical solutions;
— Healthcare data management and RWD/RWE;
— Machine learning, artificial intelligence, and digital technologies in medicine.
StereotaX focuses on topics that span the entire journey of modern medical science — from fundamental research to the implementation of solutions in clinical practice.
Key areas of interest include:
— Clinical trials and development of research infrastructure;
— Drug discovery and development;
— Preclinical research, GLP standards, and scientific data quality;
— Oncology and novel therapeutic approaches;
— Microbiology, infectious diseases, biomedicine, and biotechnology;
— Chemistry as a foundation for new pharmaceutical solutions;
— Healthcare data management and RWD/RWE;
— Machine learning, artificial intelligence, and digital technologies in medicine.
ACCELLENA headquarters:
88, lit.A., Sredniy pr. V.O.,
St. Petersburg, Russia,
199106
88, lit.A., Sredniy pr. V.O.,
St. Petersburg, Russia,
199106
Tel.: +7 (812) 337 58 66
Fax: +7 (812) 337 58 08
info@accellena.com
Fax: +7 (812) 337 58 08
info@accellena.com
Accellena's own network
Partnership network
Headquarters
